Skip to content

Pfizer’s Covid Booster Shot for Younger Teens Wins FDA Clearance

  • Third shot can be given five months after initial two doses
  • Agency also allows third doses for immune-compromised kids
Updated on

U.S. regulators cleared Pfizer Inc.’s Covid-19 booster shot for younger adolescents, widening access to additional doses as parents seek to protect their kids from the omicron wave and school officials try to keep classrooms open. 

The Food and Drug Administration said on Monday that it had granted an emergency-use authorization for people ages 12 to 15 to receive a third dose of the messenger RNA vaccine, which Pfizer developed with BioNTech SE